In tumor tissues from GC patients that were examined in vitro, AKT activation and PTEN loss were associated with increased resistance to multiple chemotherapeutic agents (5-FU, doxorubicin, mitomycin C, and cisplatin) [135]. Here, AKT1 is linked to neoplasm.